Health
Research team identifies potential drug to treat SARS-CoV-2 – Medical Xpress
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by…
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB).
The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S. Food and Drug Administration (FDA) to treat angina, a heart condition.
The team’s leaders are College of Science professor Wenshe Ray Liu, professor and…
-
General20 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General17 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News21 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General5 hours agoByford rail extension opening marks final stage of Perth Metronet